Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Outcomes of Cognitive-Behavioral Treatment for Insomnia on Insomnia, Depression, and Fatigue for Individuals with Multiple Sclerosis: A Case Series.
The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.
Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats.
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.
Role of neuroinflammation in neurodegenerative diseases (Review).
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury.
Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
A study of psychological well-being in people with multiple sclerosis and their primary caregivers.
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Combined central and peripheral demyelination.
Pages
« first
‹ previous
…
613
614
615
616
617
618
619
620
621
…
next ›
last »